Foresite Capital Management V, LLC: insider trades.
Foresite Capital Management V, LLC reported 8 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 1 open-market purchase ($2.5M) and 0 sales, across 1 company.
- Transactions
- 8
- Purchases (P)
- 1
- Sales (S)
- 0
- Companies
- 1
- Name as filed
- Foresite Capital Management V, LLC
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | TenPercentOwner | 8 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-10 | Latigo Biotherapeutics, Inc. | C | 195,776 | — | 2,203,800 | Form 4 |
| 2026-08-10 | Latigo Biotherapeutics, Inc. | P | 140,000 | $18 | 2,008,024 | Form 4 |
| 2026-08-10 | Latigo Biotherapeutics, Inc. | C | 742,201 | $0 | 1,868,024 | Form 4 |
| 2026-08-10 | Latigo Biotherapeutics, Inc. | C | 1,125,823 | $0 | 1,125,823 | Form 4 |
| 2026-08-10 | Latigo Biotherapeutics, Inc. | C | 445,320 | $0 | 3,562,984 | Form 4 |
| 2026-08-10 | Latigo Biotherapeutics, Inc. | C | 3,117,664 | $0 | 3,117,664 | Form 4 |
| 2026-08-10 | Latigo Biotherapeutics, Inc. | C | 3,117,664 | $0 | 3,117,664 | Form 4 |
| 2026-08-10 | Latigo Biotherapeutics, Inc. | C | 296,880 | $0 | 3,414,544 | Form 4 |
Questions
What stock did Foresite Capital Management V, LLC buy or sell?
Foresite Capital Management V, LLC reported 8 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 1 open-market purchase ($2.5M) and 0 sales, across 1 company.
Is Foresite Capital Management V, LLC the same person as other filers with this name?
This page covers SEC CIK 1792206 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Plain-text version for agents and LLMs: /insiders/foresite-capital-management-v-llc-1792206.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.